Filtros de búsqueda

Lista de obras de George G Zhanel

2383. In Vitro Activity of Ceftolozane–Tazobactam in Comparison With Ceftazidime–Avibactam vs. Antimicrobial Non-Susceptible Pseudomonas aeruginosa Clinical Isolates, Including Multidrug-Resistant and Extensively Drug-Resistant Subsets: CANWARD,

254In Vitro Activity of Ceftazidime in Combination with Avibactam vs 1825 Pseudomonas aeruginosa Clinical Isolates Obtained from across Canada as Part of the CANWARD Study, 2009-2013.

artículo científico publicado en 2014

A One Health Genomic Investigation of Gentamicin Resistance in Escherichia coli from Human and Chicken Sources in Canada, 2014 to 2017

artículo científico publicado en 2022

A Review of New Fluoroquinolones

article

A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections

artículo científico publicado en 2006

A critical review of the fluoroquinolones: focus on respiratory infections

artículo científico publicado en 2002

A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae

artículo científico publicado en 2004

AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity

artículo científico publicado en 2009

Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli

artículo científico publicado en 2013

Activity of Dapsone versus Community and Hospital Pathogens from the CANWARD Study

artículo científico publicado en 2016

Activity of Plazomicin against Gram-negative and Gram-positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017: CANWARD Surveillance Study

article

Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy

artículo científico publicado en 2015

Amphiphilic tobramycins with immunomodulatory properties

artículo científico publicado en 2015

Analysis of 1560 Inpatient and OutpatientEscherichia coliIsolates from across Canada—Results from the CANWARD 2007 Study

article

Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study.

artículo científico publicado en 2011

Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.

artículo científico publicado en 2009

Anti-infective research and development--problems, challenges, and solutions

artículo científico publicado en 2007

Antibacterial activities of aminoglycoside antibiotics-derived cationic amphiphiles. Polyol-modified neomycin B-, kanamycin A-, amikacin-, and neamine-based amphiphiles with potent broad spectrum antibacterial activity

artículo científico publicado en 2010

Antibacterial activity of amphiphilic tobramycin

artículo científico publicado en 2012

Antibacterial activity of guanidinylated neomycin B- and kanamycin A-derived amphiphilic lipid conjugates

artículo científico publicado en 2010

Antibacterial activity of ultrashort cationic lipo-beta-peptides

artículo científico publicado en 2009

Antibacterial drivers of resistance

artículo científico publicado en 2005

Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens

artículo científico publicado en 2006

Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

artículo científico publicado en 2018

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).

artículo científico publicado en 2003

Antibiotic resistance and expression of resistance-nodulation-division pump- and outer membrane porin-encoding genes in Acinetobacter species isolated from Canadian hospitals

artículo científico publicado en 2013

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

artículo científico publicado en 2006

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

artículo científico publicado en 2005

Antimicrobial Susceptibility of 6685 Organisms Isolated from Canadian Hospitals: CANWARD 2007

article

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.

artículo científico publicado en 2002

Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002

artículo científico publicado en 2003

Antimicrobial resistance in hospital-acquired gram-negative bacterial infections

artículo científico publicado en 2015

Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002

artículo científico publicado en 2003

Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study

artículo científico publicado en 2011

Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 study ⬇️

artículo científico publicado el 1 de marzo de 2011

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

artículo científico publicado en 2013

Antimicrobial susceptibility of 2906 Pseudomonasaeruginosa clinical isolates obtained from patients in Canadian hospitals over a period of 8 years: Results of the Canadian Ward surveillance study (CANWARD), 2008-2015.

artículo científico publicado en 2016

Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.

artículo científico publicado en 2008

Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals: CANWARD 2008-2011.

artículo científico publicado en 2012

Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study

artículo científico publicado en 2008

Antimicrobial treatment in diabetic women with asymptomatic bacteriuria

artículo científico publicado en 2002

Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

artículo científico publicado en 2008

Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.

artículo científico publicado en 2005

Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.

artículo científico publicado en 2015

Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model

artículo científico publicado en 2012

Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.

artículo científico publicado en 2009

Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine

artículo científico publicado en 2011

Biocide Selective TolC-Independent Efflux Pumps in Enterobacteriaceae

artículo científico publicado en 2017

Cadaverine Suppresses Persistence to Carboxypenicillins in Pseudomonas aeruginosa PAO1 ⬇️

artículo científico publicado el 20 de septiembre de 2010

Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae

artículo científico publicado en 2006

Canadian Practice Guidelines for Surgical Intra‐Abdominal Infections ⬇️

artículo científico publicado el 1 de enero de 2010

Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold

artículo científico publicado en 2010

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

artículo científico publicado en 2009

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination

artículo científico publicado en 2013

Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin

artículo científico publicado en 2008

Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.

artículo científico publicado en 2014

Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals

artículo científico publicado en 2013

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada

artículo científico publicado en 2013

Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–2009 study ⬇️

artículo científico publicado el 1 de marzo de 2011

Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13.

artículo científico publicado en 2015

Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit

artículo científico publicado en 2008

Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units

artículo científico publicado en 2009

Chicken as reservoir for extraintestinal pathogenic Escherichia coli in humans, Canada

artículo científico publicado en 2012

Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data

artículo científico publicado en 2014

Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data-authors' res

artículo científico publicado en 2015

Clinical implications of macrolide resistance in community-acquired respiratory tract infections

artículo científico publicado en 2006

Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults

artículo científico publicado en 2008

Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates

artículo científico publicado en 2006

Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: a Monte Carlo simulation analysis

artículo científico publicado en 2007

Comparative review of the carbapenems

artículo científico publicado en 2007

Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009.

artículo científico publicado en 2012

Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units

artículo científico publicado en 2008

Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007–2009 study

article

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoni

artículo científico publicado en 2005

Comparison of in vivo and in vitro pharmacodynamics of a humanized regimen of 600 milligrams of Ceftaroline Fosamil every 12 hours against Staphylococcus aureus at initial inocula of 106 and 108 CFU per milliliter

artículo científico publicado en 2014

Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.

artículo científico publicado en 2013

Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin

artículo científico publicado en 2012

Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.

artículo científico publicado en 2018

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario

scientific article published on 20 February 2017

Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy

artículo científico publicado en 2011

Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.

artículo científico publicado en 2008

Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity

scientific article published on 09 September 2008

Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapen

artículo científico publicado en 2009

Differences in antimicrobial susceptibility in Escherichia coli from Canadian intensive care units based on regional and demographic variables.

scientific article published on July 2008

Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claims

artículo científico publicado en 2002

ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in Manitoba

artículo científico publicado en 2007

Emergence of Antimicrobial Resistance among Pseudomonas aeruginosa: Implications for Therapy

artículo científico publicado en 2017

Emergence of antimicrobial resistance among Acinetobacter species: a global threat

artículo científico publicado en 2016

Emergence of fluoroquinolone resistance in Neisseria gonorrhoeae isolates from four clinics in three regions of Kenya

artículo científico publicado en 2012

Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004

scientific article published on 27 April 2009

Ertapenem: review of a new carbapenem

artículo científico publicado en 2005

Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy

artículo científico publicado en 2005

Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents

artículo científico publicado en 2010

Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.

artículo científico publicado en 2013

Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases).

artículo científico

Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides

artículo científico publicado en 2005

Faropenem: review of a new oral penem

artículo científico publicado en 2007

Fidaxomicin: A novel agent for the treatment of Clostridium difficile infection

artículo científico publicado en 2015

Fluoroquinolone AUIC break points and the link to bacterial killing rates: in vitro models

artículo científico publicado en 2003

Fluoroquinolone resistance in Escherichia coli isolated from patients attending Canadian hospitals is associated with the ST131 clone.

artículo científico publicado en 2011

Fluoroquinolone-associated tendinopathy: a critical review of the literature

artículo científico publicado en 2003

Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study

artículo científico publicado en 2006

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis

artículo científico publicado en 2016

Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015).

artículo científico publicado en 2016

Genetic relatedness of multidrug-resistant Escherichia coli cultured from geographically diverse outpatient, midstream urine specimens.

artículo científico publicado en 2007

Genomic analyses of DNA transformation and penicillin resistance in Streptococcus pneumoniae clinical isolates.

artículo científico publicado en 2013

Guanidylation and tail effects in cationic antimicrobial lipopeptoids

artículo científico publicado en 2012

Horizontal transfer of antibiotic resistance from Enterococcus faecium of fermented meat origin to clinical isolates of E. faecium and Enterococcus faecalis

artículo científico publicado en 2015

Hybrid Antibiotic Overcomes Resistance in P. aeruginosa by Enhancing Outer Membrane Penetration and Reducing Efflux

artículo científico publicado en 2016

Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

artículo científico publicado en 2017

In Vitro Activity of Ceftolozane-Tazobactam vs. Antimicrobial Non-Susceptible Pseudomonas aeruginosa Clinical Isolates Obtained from Across Canada as Part of the CANWARD Study, 2008–2016.

artículo científico publicado en 2017

In Vitro Activity of Colistin (Polymyxin E) Versus 2541 Pseudomonas aeruginosa Clinical Isolates Obtained From Patients in Canadian Hospitals: Results of the CANWARD Study, 2008–2014

article

In Vitro Activity of Newer Antimicrobials and Relevant Comparators Vs. 349 Stenotrophomonas maltophilia Clinical Isolates Obtained from Patients in Canadian Hospitals (CANWARD, 2011–2016).

artículo científico publicado en 2017

In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study.

scientific article published on 09 December 2013

In vitro activity of API-1252, a novel FabI inhibitor, against clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis

artículo científico publicado en 2007

In vitro activity of Iclaprim against respiratory and bacteremic isolates of Streptococcus pneumoniae

artículo científico publicado en 2009

In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile

artículo científico publicado en 2008

In vitro activity of Oritavancin against gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2015.

artículo científico publicado en 2017

In vitro activity of ceftaroline against gram-positive and gram-negative pathogens isolated from patients in Canadian hospitals in 2009.

artículo científico publicado en 2011

In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study

artículo científico publicado en 2013

In vitro activity of ceftazidime-avibactam against 338 molecularly characterized gentamicin-nonsusceptible Gram-negative clinical isolates obtained from patients in Canadian hospitals

artículo científico publicado en 2015

In vitro activity of ceftobiprole against clinical isolates of Pseudomonas aeruginosa obtained from Canadian intensive care unit (ICU) patients as part of the CAN-ICU Study

artículo científico publicado en 2008

In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007–2009 study ⬇️

artículo científico publicado el 1 de marzo de 2011

In vitro activity of ceftolozane/tazobactam versus antimicrobial non-susceptible Pseudomonas aeruginosa clinical isolates including MDR and XDR isolates obtained from across Canada as part of the CANWARD study, 2008-16.

artículo científico publicado en 2017

In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007–2009 study ⬇️

artículo científico publicado el 1 de marzo de 2011

In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014-2015.

artículo científico publicado en 2017

In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates

artículo científico publicado en 2009

In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS)

artículo científico publicado en 2009

In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002

artículo científico publicado en 2004

In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species

artículo científico publicado en 2006

Increasing genetic relatedness of ciprofloxacin-resistant Streptococcus pneumoniae isolated in Canada from 1997 to 2005.

artículo científico publicado en 2008

Infections Due to Acinetobacter baumannii in the ICU: Treatment Options

artículo científico publicado en 2017

Influence of Pharmacokinetic and Pharmacodynamic Principles on Antibiotic Selection

artículo científico publicado en 2001

Integrating pharmacokinetics, pharmacodynamics and MIC distributions to assess changing antimicrobial activity against clinical isolates of Pseudomonas aeruginosa causing infections in Canadian hospitals (CANWARD)

article

Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada

scientific article published on 25 June 2018

Introduction to the CANWARD Study (2007–2009) ⬇️

artículo científico publicado el 1 de marzo de 2011

Introduction to the CANWARD study (2007–11).

artículo científico publicado en 2013

Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.

artículo científico publicado en 2016

Investigating the antimicrobial peptide 'window of activity' using cationic lipopeptides with hydrocarbon and fluorinated tails

artículo científico publicado en 2012

In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae.

artículo científico publicado en 2015

Ketolides in the treatment of respiratory infections

artículo científico publicado en 2002

Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae

artículo científico publicado en 2003

Key research issues in Clostridium difficile

artículo científico publicado en 2005

Kisameet Clay Isolated from the Central Coast of British Columbia, Canada, Demonstrates Broad-Spectrum Antimicrobial Activity

artículo científico publicado en 2016

Launching of the CAN-R Web site -The official Web site of the Canadian Antimicrobial Resistance Alliance

artículo científico publicado en 2007

Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia

artículo científico publicado en 2020

Levofloxacin for the treatment of community-acquired pneumonia

artículo científico publicado en 2006

Limitations of ceftriaxone compared with cefazolin against MSSA: an integrated pharmacodynamic analysis.

artículo científico publicado en 2018

Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime

artículo científico publicado en 2012

Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals

artículo científico publicado en 2012

Mechanisms of resistance and mobility among multidrug-resistant CTX-M-producing Escherichia coli from Canadian intensive care units: the 1st report of QepA in North America

artículo científico publicado en 2009

Mechanisms of resistance to telithromycin in Streptococcus pneumoniae

artículo científico publicado en 2005

Microbiological Profile of Sarecycline: A Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris

artículo científico publicado en 2018

Modulation of the local neutrophil response by a novel hyaluronic acid-binding peptide reduces bacterial burden during staphylococcal wound infection.

artículo científico publicado en 2010

Molecular characterisation of Canadian paediatric multidrug-resistant Streptococcus pneumoniae from 1998-2004

artículo científico publicado en 2006

Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada

artículo científico publicado en 2003

Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.

artículo científico publicado en 2006

Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15

article

Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002

artículo científico publicado en 2005

Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11

artículo científico publicado en 2013

Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in Canada

artículo científico publicado en 2003

Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America

artículo científico publicado en 2006

Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus

artículo científico publicado en 2014

Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007

article

Multilocus sequence typing and virulence gene profiles associated with Escherichia coli from human and animal sources

artículo científico publicado en 2015

Musculoskeletal injury associated with fluoroquinolone antibiotics

artículo científico publicado en 2005

Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates

artículo científico publicado en 2004

Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa

artículo científico publicado en 2006

Neomycin-phenolic conjugates: polycationic amphiphiles with broad-spectrum antibacterial activity, low hemolytic activity and weak serum protein binding

artículo científico publicado en 2012

New biocide with both N-chloramine and quaternary ammonium moieties exerts enhanced bactericidal activity

artículo científico publicado en 2012

New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin

artículo científico publicado en 2010

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli.

artículo científico publicado en 2018

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections

artículo científico publicado en 2020

Oritavancin: mechanism of action

artículo científico publicado en 2012

Overview of seizure-inducing potential of doripenem

artículo científico publicado en 2009

PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Stud

artículo científico publicado en 2018

Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniae

artículo científico publicado en 2002

Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations

artículo científico publicado en 2003

Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro

artículo científico publicado en 2009

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum beta-lactamase-producing Escherichia coli using an in vitro model

artículo científico publicado en 2008

Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model

artículo científico publicado en 2006

Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae

artículo científico publicado en 2002

Pharmacodynamic activity of fosfomycin simulating urinary concentrations achieved after a single 3-g oral dose versus Escherichia coli using an in vitro model

artículo científico publicado en 2017

Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae

artículo científico publicado en 2006

Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations

artículo científico publicado en 2004

Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary

artículo científico publicado en 2005

Pharmacodynamic modeling of clarithromycin against macrolide-resistant [PCR-positive mef(A) or erm(B)] Streptococcus pneumoniae simulating clinically achievable serum and epithelial lining fluid free-drug concentrations

artículo científico publicado en 2002

Pharmacodynamic profiling of antimicrobials against Gram-negative respiratory isolates from Canadian hospitals

artículo científico publicado en 2011

Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP).

artículo científico publicado en 2004

Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneum

artículo científico publicado en 2008

Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data

artículo científico publicado en 2010

Pharmacokinetics/pharmacodynamics of levofloxacin 750 mg once daily in young women with acute uncomplicated pyelonephritis

artículo científico publicado en 2007

Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing

artículo científico publicado en 2017

Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination

artículo científico publicado en 2007

Polymyxin B3-Tobramycin Hybrids with Pseudomonas aeruginosa-Selective Antibacterial Activity and Strong Potentiation of Rifampicin, Minocycline, and Vancomycin

artículo científico publicado en 2017

Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada

artículo científico publicado en 2004

Preferential emergence of reduced vancomycin susceptibility in health care-associated methicillin-resistant Staphylococcus aureus isolates during continuous-infusion vancomycin therapy in an in vitro dynamic model

artículo científico publicado en 2011

Prevalence and Characterization of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Isolated in Canadian Hospitals: Results from CANWARD 2007

article

Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.

artículo científico publicado en 2011

Prevalence of Antimicrobial-Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2007)

article

Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study

artículo científico publicado en 2011

Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.

artículo científico publicado en 2011

Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).

artículo científico publicado en 2010

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

artículo científico publicado en 2016

Role of efflux mechanisms on fluoroquinolone resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa

artículo científico publicado en 2004

Role of glycoside hydrolase genes in sinigrin degradation by E. coli O157:H7.

artículo científico publicado en 2015

Scissors: a potential source of nosocomial infection

artículo científico publicado en 2002

Selection of a gyrA mutation and treatment failure with gatifloxacin in a patient with Streptococcus pneumoniae with a preexisting parC mutation

artículo científico publicado en 2007

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

article

Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010.

artículo científico publicado en 2012

Serotype distribution of invasive Streptococcus pneumoniae in adults 65 years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016

article

Short Antimicrobial Peptides and Peptide Scaffolds as Promising Antibacterial Agents

artículo científico

Short proline-rich lipopeptide potentiates minocycline and rifampicin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa

artículo científico publicado en 2018

Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia

artículo científico publicado en 2016

Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutants

artículo científico publicado en 2005

Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance

artículo científico publicado en 2016

Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly

artículo científico publicado en 2016

Streptococcus pneumoniae: does antimicrobial resistance matter?

artículo científico publicado en 2009

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines

artículo científico publicado en 2010

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention

artículo científico publicado en 2009

Stretching the mutant prevention concentration (MPC) beyond its limits

artículo científico publicado en 2003

Structure-activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity

artículo científico publicado en 2014

Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin Measured by Four In Vitro Testing Methods

artículo científico publicado en 2020

Synthesis and antibacterial activities of amphiphilic neomycin B-based bilipid conjugates and fluorinated neomycin B-based lipids

artículo científico publicado en 2012

Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates

artículo científico publicado en 2011

Synthesis and antibacterial properties of carbohydrate-templated lysine surfactants ⬇️

artículo científico publicado el 28 de enero de 2011

Synthesis of glucose-templated lysine analogs and incorporation into the antimicrobial dipeptide sequence kW-OBn

artículo científico publicado en 2008

Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

artículo científico publicado en 2015

Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance

artículo científico publicado en 2015

Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia

artículo científico publicado en 2006

The Use of Ketolides in Treatment of Upper Respiratory Tract Infections

artículo científico publicado en 2004

The Use of Macrolides in Treatment of Upper Respiratory Tract Infections.

artículo científico publicado en 2005

The glycylcyclines: a comparative review with the tetracyclines

artículo científico publicado en 2004

The ketolides: a critical review

artículo científico publicado en 2002

The use of macrolides in treatment of upper respiratory tract infections

artículo científico publicado en 2006

Tigecycline: a novel glycylcycline antibiotic

artículo científico publicado en 2006

Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa.

artículo científico publicado en 2018

Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum- -lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate

artículo científico publicado en 2006

Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11.

artículo científico publicado en 2013

Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics

artículo científico publicado en 2014

Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment.

artículo científico publicado en 2006

Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda